$301 Million is the total value of Defender Capital, LLC.'s 40 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ARWR | Exit | ARROWHEAD PHARMACUTICLES | $0 | – | -4,000 | -100.0% | -0.10% | – |
CDMO | Exit | AVID BIOSERVICES INC | $0 | – | -30,000 | -100.0% | -0.20% | – |
VNT | Exit | VONTIER CORP | $0 | – | -74,201 | -100.0% | -0.80% | – |
PTN | Exit | PALANTIR TECHNOLOGIES | $0 | – | -10,000 | -100.0% | -0.83% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-07-29
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BERKSHIRE HATHAWAY INC DEL CL B | 20 | Q3 2023 | 24.4% |
DANAHER CORPORATION COM | 20 | Q3 2023 | 18.3% |
STAAR SURGICAL CORPORATION | 20 | Q3 2023 | 20.2% |
FORTIVE CORPORATION | 20 | Q3 2023 | 14.3% |
MONSTER BEVERAGE CORPORATION | 20 | Q3 2023 | 17.3% |
APPLE INC | 20 | Q3 2023 | 0.6% |
AMAZON INC COM | 20 | Q3 2023 | 0.4% |
VANGUARD SHORT TERM TREASURY ETF IV | 17 | Q3 2023 | 23.9% |
LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 4.8% |
COMPUGEN LTD ORD | 17 | Q1 2023 | 1.9% |
View Defender Capital, LLC.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-06 |
13F-HR | 2024-01-23 |
13F-HR | 2023-10-23 |
13F-HR | 2023-07-18 |
13F-HR/A | 2023-05-16 |
13F-HR | 2023-04-27 |
13F-HR | 2023-01-12 |
13F-HR | 2022-10-18 |
13F-HR | 2022-07-26 |
13F-HR/A | 2022-06-07 |
View Defender Capital, LLC.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.